# Caffeine in the Second Stage of Labor in Low-risk Nulliparous Mothers at Term

> **NCT05906303** · PHASE1 · UNKNOWN · sponsor: **The Reading Hospital and Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Second Stage of Labor

## Interventions

- **DRUG:** Caffeine and Sodium Benzoate Injection
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT05906303
- **Lead sponsor:** The Reading Hospital and Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05906303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05906303, "Caffeine in the Second Stage of Labor in Low-risk Nulliparous Mothers at Term". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05906303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*